These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3979005)

  • 21. Cyclosporin versus etretinate: Italian multicenter comparative trial in severe plaque-form psoriasis. Italian Multicenter Study Group on Cyclosporin in Psoriasis.
    Dermatology; 1993; 187 Suppl 1():8-18. PubMed ID: 8369579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of pregnancy on the pharmacokinetic disposition of two aromatic retinoids (etretinate and acitretin) in the rat. II. Single and multiple oral dosing studies.
    Brouwer KR; McNamara PJ
    Drug Metab Dispos; 1989; 17(6):652-5. PubMed ID: 2575502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of generalized pustular psoriasis with etretinate (Ro 10-9359) and methotrexate.
    Rosenbaum MM; Roenigk HH
    J Am Acad Dermatol; 1984 Feb; 10(2 Pt 2):357-61. PubMed ID: 6707259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Etretinate for psoriasis.
    Med Lett Drugs Ther; 1987 Jan; 29(731):9-10. PubMed ID: 3540554
    [No Abstract]   [Full Text] [Related]  

  • 25. Etretinate therapy reduces polymorphonuclear leukocyte chemotaxis--enhancing properties of psoriatic serum.
    Ellis CN; Kang S; Grekin RC; Voorhees JJ; Silva J
    J Am Acad Dermatol; 1985 Sep; 13(3):437-43. PubMed ID: 4056118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Etretinate improves localized porokeratosis of Mibelli.
    Campbell JP; Voorhees JJ
    Int J Dermatol; 1985 May; 24(4):261-3. PubMed ID: 4008158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acitretin is converted to etretinate only during concomitant alcohol intake.
    Grønhøj Larsen F; Steinkjer B; Jakobsen P; Hjorter A; Brockhoff PB; Nielsen-Kudsk F
    Br J Dermatol; 2000 Dec; 143(6):1164-9. PubMed ID: 11122016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tigason (etretinate) treatment in psoriatic arthritis.
    Ciompi ML; Bazzichi L; Marotta G; Pasero G
    Int J Tissue React; 1988; 10(1):25-7. PubMed ID: 3397251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retinoids and psoriasis.
    Orfanos CE
    Acta Derm Venereol Suppl (Stockh); 1984; 112():37-41. PubMed ID: 6596824
    [No Abstract]   [Full Text] [Related]  

  • 30. Tissue distribution of aromatic retinoid (etretinate) in three autopsy cases: drug accumulation in adrenals and fat.
    Vahlquist A; Rollman O; Pihl-Lundin I
    Acta Derm Venereol; 1986; 66(5):431-4. PubMed ID: 2431582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Etretinate. A review of its pharmacological properties and therapeutic efficacy in psoriasis and other skin disorders.
    Ward A; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1983 Jul; 26(1):9-43. PubMed ID: 6224672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of 14C-etretinate in healthy volunteers and two patients with biliary T-tube drainage.
    Lucek RW; Dickerson J; Carter DE; Bugge CJ; Crews T; Vane FM; Cunningham W; Colburn WA
    Biopharm Drug Dispos; 1988; 9(5):487-99. PubMed ID: 3066416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generalized pustular psoriasis in a child: observation of long-term combination therapy with etretinate and calcipotriol for 16 years.
    Umezawa Y; Mabuch T; Ozawa A
    Pediatr Dermatol; 2012; 29(2):206-8. PubMed ID: 22409471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Use of etretinate (RO-10-9359) in intermittent doses and follow-up for 1 year in patients with psoriasis. Final report].
    Domínguez Soto L; Hokyo Tomoka MT; Armas JJ
    Med Cutan Ibero Lat Am; 1984; 12(1):47-56. PubMed ID: 6376979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucose and insulin responses are improved in patients with psoriasis during therapy with etretinate.
    Ellis CN; Kang S; Vinik AI; Grekin RC; Cunningham WJ; Voorhees JJ
    Arch Dermatol; 1987 Apr; 123(4):471-5. PubMed ID: 3548599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acitretin versus etretinate in severe psoriasis. A double-blind randomized Nordic multicenter study in 168 patients.
    Bjerke JR; Geiger JM
    Acta Derm Venereol Suppl (Stockh); 1989; 146():206-7. PubMed ID: 2532847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The treatment of psoriasis with etretinate and acitretin: a follow up of actual use.
    Magis NL; Blummel JJ; Kerkhof PC; Gerritsen RM
    Eur J Dermatol; 2000; 10(7):517-21. PubMed ID: 11056421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A double-blind comparison of acitretin and etretinate in the treatment of severe psoriasis. Results of a Nordic multicentre study.
    Kragballe K; Jansén CT; Geiger JM; Bjerke JR; Falk ES; Gip L; Hjorth N; Lauharanta J; Mork NJ; Reunala T
    Acta Derm Venereol; 1989; 69(1):35-40. PubMed ID: 2563606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of 3 times a day dosing of oral treprostinil in healthy volunteers.
    Jones A; Wang-Smith L; Pham T; Laliberte K
    J Cardiovasc Pharmacol; 2014 Mar; 63(3):227-32. PubMed ID: 24603117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pharmacokinetics of acitretin and its 13-cis-metabolite in psoriatic patients.
    Larsen FG; Jakobsen P; Eriksen H; Grønhøj J; Kragballe K; Nielsen-Kudsk F
    J Clin Pharmacol; 1991 May; 31(5):477-83. PubMed ID: 1828811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.